The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts

Blood

Volumn 92, Issue 9, 1998, Pages 3025-3034

  Chesi, Marta ^a   Nardini, Elena ^a   Lim, Robert S C ^a   Smith, Kerrington D ^a   Michael Kuehl, W ^a   Bergsagel, P Leif ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; MESSENGER RNA;

ALTERNATIVE RNA SPLICING; ARTICLE; CELL TRANSFORMATION; CHROMOSOME 14; CHROMOSOME 4P; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; NUCLEOTIDE SEQUENCE; ONCOGENE; POLYADENYLATION; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; TELOMERE; TESTIS; THYMUS;

EID: 0032212243     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.9.3025     Document Type: Article

References (32)

1. Korsmeyer SJ: Chromosomal translocations in lymphoid malignancies reveal novel proto-oncogenes. Annu Rev Immunol 10:785, 1992
2. Bergsagel PL, Chesi M, Nardini E, Brents LA, Kirby SL, Kuehl WM: Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma. Proc Natl Acad Sci USA 93:13931, 1996
3. Chesi M, Bergsagel PL, Brents LA, Smith CM, Gerhard DS, Kuehl WM: Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines. Blood 88:674, 1996
4. Chesi M, Nardini E, Brents LA, Schrock E, Ried T, Kuehl WM, Bergsagel PL: Frequent translocation t(4; 14)(p16.3; q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3. Nat Genet 16:260, 1997
5. Chesi M, Bergsagel PL, Shonukan OO, Martelli ML, Brents LA, Chen T, Schröck E, Ried T, Kuehl WM: Frequent dysregulation of the c-maf protooncogene at 16q23 by translocation to an immunoglobulin locus in multiple myeloma. Blood 91:4457, 1998
6. Calasanz MJ, Cigudosa JC, Odero MD, Ferreira C, Ardanaz MT, Fraile A, Carrasco JL, Sole F, Cuesta B, Gullon A: Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: Primary breakpoints and clinical correlations. Genes Chromosomes Cancer 18:84, 1997
7. Lai JL, Zandecki M, Mary JY, Bernardi F, Izydorczyk V, Flactif M, Morel P, Jouet JP, Bauters F, Facon T: Improved cytogenetics in multiple myeloma: A study of 151 patients including 117 patients at diagnosis. Blood 85:2490, 1995
8. Sawyer JR, Waldron JA, Jagannath S, Barlogie B: Cytogenetic findings in 200 patients with multiple myeloma. Cancer Genet Cytogenet 82:41, 1995
9. Nishida K, Tamura A, Nakazawa N, Ueda Y, Abe T, Matsuda F, Kashima K, Taniwaki M: The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization. Blood 90:526, 1997
10. Baxendale S, MacDonald ME, Mott R, Francis F, Lin C, Kirby S, James M, Zehetner G, Hummerich H, Valdes J, Collins FS, Deaven U, Gusella JF, Lehrach H, Bates GP: A cosmid contig and high resolution restriction map of the 2 megabase region containing the Huntington's disease gene. Nat Genet 4:181, 1993
11. Uberbacher EC, Mural RJ: Locating protein-coding regions in human DNA sequences by a multiple sensor-neural network approach, Proc Natl Acad Sci USA 88:11261, 1991
12. Solovyev VV, Salamov AA, Lawrence CB: Identification of human gene structure using linear discriminant functions and dynamic programming. Intelligent Systems Mol Biol 3:367, 1995
13. Prestridge DS: Predicting Pol II promoter sequences using transcription factor binding sites. J Mol Biol 249:923, 1995
14. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ: Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res 25:3389, 1997
15. Baxevanis AD, Landsman D: The HMG-1 box protein family: Classification and functional relationships. Nucleic Acids Res 23:1604, 1995
16. Izumoto Y, Kuroda T, Harada H. Kishimoto T, Nakamura H: Hepatoma-derived growth factor belongs to a gene family in mice showing significant homology in the amino terminus. Biochem Biophys Res Commun 238:26, 1997
17. Aasland R, Gibson TJ, Stewart AF: The PHD finger: Implications for chromatin-mediated transcriptional regulation. Trends Biochem Sci 20:56, 1995
18. Stassen MJ, Bailey D, Nelson S, Chinwalla V, Harte PJ: The Drosophila trithorax proteins contain a novel variant of the nuclear receptor type DNA binding domain and an ancient conserved motif found in other chromosomal proteins. Mech Dev 52:209, 1995
19. Tschiersch B, Hofmann A, Krauss V, Dorn R, Korge G, Reuter G: The protein encoded by the Drosophila position-effect variegation suppressor gene Su(var)3-9 combines domains of antagonistic regulators of homeotic gene complexes. EMBO J 13:3822, 1994
20. Gould A: Functions of mammalian Polycomb group and trithorax group related genes. Curr Opin Genet Dev 7:488, 1997
21. Huang N, vom Baur E, Garnier JM, Lerouge T, Vonesch JL. Lutz Y, Chambon P, Losson R: Two distinct nuclear receptor interaction domains in NSD1, a novel SET protein that exhibits characteristics of both corepressors and coactivators. EMBO J 17:3398, 1998
22. Ye BH, Chaganti S, Chang CC, Niu H, Corradini P, Chaganti RS, Dalla-Favera R: Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B cell lymphoma. EMBO J 14:6209, 1995
23. Bachl J, Turck CW, Wabl M: Translatable immunoglobulin germ-line transcript. Eur J Immunol 26:870, 1996
24. Kozak M: Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell 44:283, 1986
25. Cui X, De Vivo I, Slany R, Miyamoto A, Firestein R, Cleary ML: Association of SET domain and myotubularin-related proteins modulates growth control [see comments]. Nat Genet 18:331, 1998
26. Waring PM, Cleary ML: Disruption of a homolog of trithorax by 11q23 translocations: Leukemogenic and transcriptional implications. Curr Top Microbiol Immunol 220:1, 1997
27. Yu BD, Hess JL, Horning SE, Brown GA, Korsmeyer SJ: Altered Hox expression and segmental identity in Mll-mutant mice. Nature 378:505, 1995
28. Lurie IW, Lazjuk GI, Ussova YI, Presman EB, Gurevich DB: The Wolf-Hirschhorn syndrome. I. Genetics. Clin Genet 17:375, 1980
29. Wilson MG, Towner JW, Coffin GS, Ebbin AJ, Siris E, Brager P: Genetic and clinical studies in 13 patients with the Wolf-Hirschhorn syndrome [del(4p)]. Hum Genet 59:297, 1981
30. Wright TJ, Ricke DO, Denison K, Abmayr S, Cotter PD, Hirschhorn K, Keinanen M, McDonald-McGinn D, Somer M, Spinner N, Yang-Feng T, Zackai E, Altherr MR: A transcript map of the newly defined 165 kb Wolf-Hirschhorn syndrome critical region. Hum Mol Genet 6:317, 1997
31. Mills FC, Harindranath N, Mitchell M, Max EE: Enhancer complexes located downstream of both human immunoglobulin Calpha genes, J Exp Med 186:845, 1997
32. Stec I, Wright TJ, van OG, de BP, van Haeringen A, Moorman A, Altherr MR, den Dunnen JT: WHSC1, a 90 kb SET domain-containing gene, expressed in early development and homologous to a drosophila dysmorphy gene maps in the Wolf-Hirschhorn syndrome critical region and is fused to IgH in t(4;14) multiple myeloma. Hum Mol Genet 7:1071, 1998